Regulation of urokinase expression at the posttranscription level by lung epithelial cells

Biochemistry

Volumn 51, Issue 1, 2012, Pages 205-213

  Shetty, Shwetha K ^a   Marudamuthu, Amarnath S ^a   Abernathy, Daniel ^a   Shetty, Rashmi S ^a   Shetty, Praveenkumar ^a,c   Fu, Jian ^a   Idell, Steven ^a   Bhandary, Yashodhar P ^a   Ji, Honglong ^a   Liu, Ming Cheh ^b   Shetty, Sreerama ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEINS; CELL LYSATES; EPITHELIAL CELLS; IMMUNOPRECIPITATIONS; LUNG EPITHELIAL CELLS; LUNG INFLAMMATION; MRNA EXPRESSION; MRNA STABILITY; OVER-EXPRESSION; RIBONUCLEOTIDE REDUCTASE; TIME-DEPENDENT; UROKINASE EXPRESSION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA);

CELLS; CYTOLOGY; STABILIZATION;

PROTEINS;

MESSENGER RNA; RECOMBINANT ENZYME; RIBONUCLEOTIDE REDUCTASE; UROKINASE;

ARTICLE; HUMAN; IMMUNOPRECIPITATION; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY; UNTRANSLATED REGION;

ANIMALS; CELL LINE; CELLS, CULTURED; ENZYME STABILITY; HUMANS; LIPOPOLYSACCHARIDES; LUNG; MICE; RECOMBINANT PROTEINS; RESPIRATORY MUCOSA; RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84856866729     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi201293x     Document Type: Article

References (30)

1. Dumler, I., Petri, T., and Schleuning, W. D. (1993) Interaction of urokinase-type plasminogenactivator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kda protein. FEBS Lett. 322, 37-40. (Pubitemid 23122380)
2. Shetty, S., Pendurthi, U. R., Halady, P. K., Azghani, A. O., and Idell, S. (2002) Urokinase induces its own expression in Beas2b lung epithelial cells. Am. J. Physiol Lung Cell Mol. Physiol 283, L319-L328. (Pubitemid 34803988)
3. Koopman, J. L., Slomp, J., de Bart, A. C., Quax, P. H., and Verheijen, J. H. (1998) Effects of urokinase on melanoma cells are independent of high affinity binding to the urokinase receptor. J. Biol. Chem. 273, 33267-33272. (Pubitemid 29005701)
4. Koshelnick, Y., Ehart, M., Hufnagl, P., Heinrich, P. C., and Binder, B. R. (1997) Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line tcl-598. J. Biol. Chem. 272, 28563-28567. (Pubitemid 27517808)
5. Bhat, G. J., Gunaje, J. J., and Idell, S. (1999) Urokinase-type plasminogen activator induces tyrosine phosphorylation of a 78-kDa protein in H-157 cells. Am. J. Physiol. 277, L301-L309. (Pubitemid 29415087)
6. Shetty, S., Bdeir, K., Cines, D. B., and Idell, S. (2003) Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells. J. Biol. Chem. 278, 18124-18131. (Pubitemid 36799426)
7. Abraham, E., Gyetko, M. R., Kuhn, K., Arcaroli, J., Strassheim, D., Park, J. S., Shetty, S., and Idell, S. (2003) Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. J. Immunol. 170, 5644-5651. (Pubitemid 36617856)
8. Abraham, E., Matthay, M. A., Dinarello, C. A., Vincent, J. L., Cohen, J., Opal, S. M., Glauser, M., Parsons, P., Fisher, C. J. Jr., and Repine, J. E. (2000) Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit. Care Med. 28, 232-235. (Pubitemid 30091059)
9. Welty-Wolf, K. E., Carraway, M. S., Ortel, T. L., Ghio, A. J., Idell, S., Egan, J., Zhu, X., Jiao, J. A., Wong, H. C., and Piantadosi, C. A. (2006) Blockade of tissue factor-factor X binding attenuates sepsisinduced respiratory and renal failure. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L21-L31.
10. Robbie, L. A., Dummer, S., Booth, N. A., Adey, G. D., and Bennett, B. (2000) Plasminogen activator inhibitor 2 and urokinasetype plasminogen activator in plasma and leucocytes in patients with severe sepsis. Br. J. Hamaetol. 109, 342-348. (Pubitemid 30350715)
11. Bhandary, Y. P., Velusamy, T., Shetty, P., Shetty, R. S., Idell, S., Cines, D. B., Jain, D., Bdeir, K., Abraham, E., Tsuruta, Y., and Shetty, S. (2009) Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury. Am. J. Respir. Crit. Care Med. 179, 288-298.
12. Shetty, S., and Idell, S. (2001) Urokinase induces expression of its own receptor in Beas2b lung epithelial cells. J. Biol. Chem. 276, 24549-24556.
13. Li, C., Zhang, J., Jiang, Y., Gurewich, V., Chen, Y., and Liu, J. N. (2001) Urokinase-type plasminogen activator up-regulates its own expression by endothelial cells and monocytes via the u-PAR pathway. Thromb. Res. 103, 221-232. (Pubitemid 32728107)
14. Gyetko, M. R., Aizenberg, D., and Mayo-Bond, L. (2004) Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro. J. Leukoc. Biol. 76, 648-656. (Pubitemid 39129098)
15. Shetty, S., and Idell, S. (2000) Identification of a novel urokinase mRNA-binding protein in human lung epithelial cells in vitro. J. Biol. Chem. 275, 13771-13779.
16. Shetty, S., Velusamy, T., Shetty, R. S., Marudamuthu, A. S., Shetty, S. K., Florova, G., Tucker, T., Koenig, K., Shetty, P., Bhandary, Y. P., and Idell, S. (2010) Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 43, 358-367.
17. Shetty, S., Ganachari, M., Liu, M. C., Azghani, A., Muniyappa, H., and Idell, S. (2005) Regulation of urokinase receptor expression by phosphoglycerate kinase is independent of its catalytic activity. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L591-L598. (Pubitemid 41361669)
18. Shetty, S., Muniyappa, H., Halady, P. K., and Idell, S. (2004) Regulation of urokinase receptor expression by phosphoglycerate kinase. Am. J. Respir. Cell Mol. Biol. 31, 100-106. (Pubitemid 38888045)
19. Shetty, S., Kumar, A., and Idell, S. (1997) Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol. Cell. Biol. 17, 1075-1083. (Pubitemid 27097336)
20. Erbacher, P., Remy, J. S., and Behr, J. P. (1999) Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther. 6, 138-145. (Pubitemid 29043704)
21. Shetty, S. (2002) Cytoplasmic-nuclear shuttling of the urokinase mRNA binding protein regulates message stability. Mol. Cell. Biochem. 237, 55-67. (Pubitemid 34965793)
22. Shetty, S. (2005) Protein synthesis and urokinase mRNA metabolism. Mol. Cell. Biochem. 271, 13-22. (Pubitemid 40528458)
23. Philippe, J., Offner, F., Declerck, P. J., Leroux-Roels, G., Vogelaers, D., Baele, G., and Collen, D. (1991) Fibrinolysis and coagulation in patients with infectious disease and sepsis. Thromb. Haemost. 65, 291-295.
24. Wygrecka, M., Markart, P., Ruppert, C., Kuchenbuch, T., Fink, L., Bohle, R. M., Grimminger, F., Seeger, W., and Gunther, A. (2004) Compartment-and cell-specific expression of coagulation and fibrinolysis factors in the murine lung undergoing inhalational versus intravenous endotoxin application. Thromb. Haemost. 92, 529-540. (Pubitemid 39248009)
25. Kwak, S. H., Mitra, S., Bdeir, K., Strassheim, D., Park, J. S., Kim, J. Y., Idell, S., Cines, D., and Abraham, E. (2005) Abraham E. The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}-v{beta}3 integrins. J. Leukoc. Biol. 78, 937-945. (Pubitemid 41384410)
26. Shetty, P., Velusamy, T., Bhandary, Y. P., Shetty, R. S., Liu, M. C., and Shetty, S. (2008) Urokinase expression by tumor suppressor protein p53: a novel role in mRNA turnover. Am. J. Respir. Cell Mol. Biol. 39, 364-372.
27. Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., and Nakamura, Y. (2000) A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404, 42-49. (Pubitemid 30143125)
28. Zhang, Y. W., Jones, T. L., Martin, S. E., Caplen, N. J., and Pommier, Y. (2009) Implication of checkpoint kinase-dependent upregulation of ribonucleotide reductase R2 in DNA damage response. J. Biol. Chem. 284, 18085-18095.
29. Zhou, B., Liu, X., Mo, X., Xue, L., Darwish, D., Qiu, W., Shih, J., Hwu, E. B., Luh, F., and Yen, Y. (2003) The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UVinduced DNA repair in cells with mutant p53. Cancer Res. 63, 6583-6594. (Pubitemid 37322936)
30. Xue, L., Zhou, B., Liu, X., Qiu, W., Jin, Z., and Yen, Y. (2003) Wild-type P53 regulates human ribonucleotide reductase by proteinprotein interaction with P53R2 as well as hRRM2 subunits. Cancer Res. 63, 980-986. (Pubitemid 36278428)